Your browser doesn't support javascript.
loading
Development and Prospective Validation of a Risk Calculator That Predicts a Low Risk Cohort for Atypical Ductal Hyperplasia Upstaging to Malignancy: Evidence for a Watch and Wait Strategy of a High-Risk Lesion.
Lustig, Daniel Ben; Guo, Michael; Liu, Claire; Warburton, Rebecca; Dingee, Carol K; Pao, Jin-Si; Kuusk, Urve; Chen, Leo; McKevitt, Elaine C.
Afiliação
  • Lustig DB; Department of Surgery, Vancouver Coastal Health, 2775 Laurel Street, 11th Floor, Vancouver, BC, V5Z 1M9, Canada. daniel.lustig@alumni.ubc.ca.
  • Guo M; University of British Columbia, Vancouver, Canada. daniel.lustig@alumni.ubc.ca.
  • Liu C; University of British Columbia, Vancouver, Canada.
  • Warburton R; University of British Columbia, Vancouver, Canada.
  • Dingee CK; University of British Columbia, Vancouver, Canada.
  • Pao JS; Providence Health Care, Vancouver, Canada.
  • Kuusk U; University of British Columbia, Vancouver, Canada.
  • Chen L; Providence Health Care, Vancouver, Canada.
  • McKevitt EC; University of British Columbia, Vancouver, Canada.
Ann Surg Oncol ; 27(12): 4622-4627, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32710273
ABSTRACT

BACKGROUND:

Guidelines recommend surgical excision of atypical ductal hyperplasia (ADH) due to the concern of undersampling a potential malignancy on core needle biopsy (CNB). The purpose of this study was to determine clinical, radiological and pathological variables associated with ADH upstaging to cancer and to develop a predictive risk calculator capable of identifying women who have a low oncological risk of upstaging.

METHODS:

A prospectively collected database from a tertiary breast referral center was analyzed for women diagnosed with ADH on CNB between January 2013 to December 2017 who underwent surgical excision. CNB and surgical pathology reports were examined to determine rate of upstaging. The association between clinical, radiological and pathological variables were evaluated using regression analysis to determine predictors of ADH upstaging to cancer. Significant variables (p ≤ 0.05) identified on univariate analysis were assigned a score of "1" and were included in the ADH upstaging risk calculator.

RESULTS:

A total of 1986 patients underwent surgery for a high-risk lesion. We identified 318 (16.0%) patients who had ADH identified on their CNB who underwent surgery-of which 290 were included in our study. The upstage rate was 24.8%. Five variables were associated with upstaging and included in our calculator (1) lesion > 5 mm on ultrasound; (2) lesion > 5 mm on mammogram; (3) one or more "high-risk" lesion(s) on CNB; (4) pathological suspicion for cancer and; (5) incomplete removal of calcifications on CNB. Patients with a score of 0 had a 2% risk of being upstaged to cancer and were deemed low risk with 17.2% of patients falling within this category.

CONCLUSIONS:

Patients with ADH on CNB can be stratified into a low oncological cohort who have a 2% risk of being upstaged to carcinoma. In the future, these select patients may be counselled and potentially offered observation as an alternative to surgery.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Intraductal não Infiltrante Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Intraductal não Infiltrante Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article